Note 11 - Grants and Collaboration Revenue |
9 Months Ended |
---|---|
Sep. 30, 2018 | |
Notes to Financial Statements | |
Government Grants and Contracts [Text Block] | 11. Grants and Collaboration RevenueWe receive payments from government entities under our grants from the National Institute of Allergy and Infectious Diseases (NIAID) and from the U.S. Department of Defense in support of our vaccine research and development efforts. We record revenue associated with government grants as the reimbursable costs are incurred. During the three -month and nine -month periods ended September 30, 2018, we recorded $340,716 and $650,280, respectively, of revenues associated with these grants, as compared to $247,994 and $800,866, respectively, for the comparable periods of 2017. As of September 30, 2018, there is an aggregate of $2,873,542 in approved grant and contract funds available for use.During the three -month and nine -month periods ended September 30, 2018, we recorded $8,628 and $13,628, respectively, of revenues associated with research collaboration agreements with several third parties, as compared to $-0 - and $95,000, respectively, for the comparable periods of 2017. |